Abstract
To identify susceptibility alleles associated with rheumatoid arthritis, we genotyped 397 individuals with rheumatoid arthritis for 116,204 SNPs and carried out an association analysis in comparison to publicly available genotype data for 1,211 related individuals from the Framingham Heart Study1. After evaluating and adjusting for technical and population biases, we identified a SNP at 6q23 (rs10499194, ∼150 kb from TNFAIP3 and OLIG3) that was reproducibly associated with rheumatoid arthritis both in the genome-wide association (GWA) scan and in 5,541 additional case-control samples (P = 10−3, GWA scan; P < 10−6, replication; P = 10−9, combined). In a concurrent study, the Wellcome Trust Case Control Consortium (WTCCC) has reported strong association of rheumatoid arthritis susceptibility to a different SNP located 3.8 kb from rs10499194 (rs6920220; P = 5 × 10−6 in WTCCC)2. We show that these two SNP associations are statistically independent, are each reproducible in the comparison of our data and WTCCC data, and define risk and protective haplotypes for rheumatoid arthritis at 6q23.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Herbert, A. et al. A common genetic variant is associated with adult and childhood obesity. Science 312, 279–283 (2006).
The Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661–678 (2007).
Silman, A.J. & Pearson, J.E. Epidemiology and genetics of rheumatoid arthritis. Arthritis Res. 4 (Suppl. 3), S265–S272 (2002).
Irigoyen, P. et al. Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles. Arthritis Rheum. 52, 3813–3818 (2005).
Begovich, A.B. et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am. J. Hum. Genet. 75, 330–337 (2004).
Clayton, D.G. et al. Population structure, differential bias and genomic control in a large-scale, case-control association study. Nat. Genet. 37, 1243–1246 (2005).
Freedman, M.L. et al. Assessing the impact of population stratification on genetic association studies. Nat. Genet. 36, 388–393 (2004).
Marchini, J., Cardon, L.R., Phillips, M.S. & Donnelly, P. The effects of human population structure on large genetic association studies. Nat. Genet. 36, 512–517 (2004).
Devlin, B. & Roeder, K. Genomic control for association studies. Biometrics 55, 997–1004 (1999).
Purcell, S. et al. PLINK: a toolset for whole genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559–575 (2007).
Price, A.L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904–909 (2006).
Stolt, P. et al. Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann. Rheum. Dis. 62, 835–841 (2003).
Jawaheer, D., Lum, R.F., Amos, C.I., Gregersen, P.K. & Criswell, L.A. Clustering of disease features within 512 multicase rheumatoid arthritis families. Arthritis Rheum. 50, 736–741 (2004).
de Bakker, P.I. et al. Efficiency and power in genetic association studies. Nat. Genet. 37, 1217–1223 (2005).
Graham, R.R. et al. Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc. Natl. Acad. Sci. USA 104, 6758–6763 (2007).
Duerr, R.H. et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314, 1461–1463 (2006).
Haiman, C.A. et al. Multiple regions within 8q24 independently affect risk for prostate cancer. Nat. Genet. 39, 638–644 (2007).
Yeager, M. et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat. Genet. 39, 645–649 (2007).
Gudmundsson, J. et al. Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat. Genet. 39, 631–637 (2007).
Maller, J. et al. Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nat. Genet. 38, 1055–1059 (2006).
Opipari, A.W. Jr., Boguski, M.S. & Dixit, V.M. The A20 cDNA induced by tumor necrosis factor alpha encodes a novel type of zinc finger protein. J. Biol. Chem. 265, 14705–14708 (1990).
Elliott, M.J. et al. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet 344, 1105–1110 (1994).
Lee, E.G. et al. Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science 289, 2350–2354 (2000).
Muller, T. et al. The bHLH factor Olig3 coordinates the specification of dorsal neurons in the spinal cord. Genes Dev. 19, 733–743 (2005).
Sato, M. et al. The validity of a rheumatoid arthritis medical records-based index of severity compared with the DAS28. Arthritis Res. Ther. 8, R57 (2006).
Mitchell, M.K., Gregersen, P.K., Johnson, S., Parsons, R. & Vlahov, D. The New York Cancer Project: rationale, organization, design, and baseline characteristics. J. Urban Health 81, 301–310 (2004).
Seldin, M.F. et al. European population substructure: clustering of northern and southern populations. PLoS Genet. 2, e143 (2006).
Purcell, S., Daly, M.J. & Sham, P.C. WHAP: haplotype-based association analysis. Bioinformatics 23, 255–256 (2007).
Acknowledgements
The Framingham Heart Study is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with Boston University. This manuscript was not prepared in collaboration with investigators of the Framingham Heart Study and does not necessarily reflect the opinions or views of the Framingham Heart Study, Boston University or NHLBI. We appreciate the comments provided by B. Voight and J. Hirschhorn during the preparation of the manuscript. We appreciate the release of genome-wide association results by the WTCCC, which was of great value to our analysis. The BRASS Registry is supported by a grant from Millennium Pharmaceuticals and Biogen-Idec. R.M.P. is supported by a K08 grant from the US National Institutes of Health (AI55314-3). The NARAC is supported by US National Institutes of Health grants RO1-AR44422 and NO1-AR-2-2263 (P.K.G.). This work was also supported in part by the Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health. The EIRA study is supported by grants from the Swedish Medical Research Council, the Swedish Council for Working Life and Social Research, King Gustaf V's 80-Year Foundation, the Swedish Rheumatic Foundation, the Stockholm County Council, the insurance company Arbetsmarknadens Försäkringsaktiebolag and the County of Sörmland Research and Development Center. D.A. is a Burroughs Wellcome Fund Clinical Scholar in Translational Research and a Distinguished Clinical Scholar of the Doris Duke Charitable Foundation.
Author information
Authors and Affiliations
Contributions
Clinical samples were collected and prepared by R.M.P., E.W.K., N.M., D.M.L., E.F.R., A.T.L., L.P., L.A., J.C., M.E.W., L.K., P.K.G. and N.A.S. Genotyping was contributed by R.M.P., L.D., N.P.B., B.B., M.D., M.P., R.B., W.W., C.H., D.A.H., S.B.G., M.F.S., E.I., R.R. and A.N.P. Statistical analysis was carried out and interpreted by R.M.P., C.C., L.D., A.L.P., P.I.W.D., J.M., I.P., R.R.G., R.G., S.P., M.J.D. and D.A. The manuscript was written by R.M.P., C.C., M.J.D. and D.A.
Corresponding author
Ethics declarations
Competing interests
R.R., A.N.P. and E.I. were employed by Millennium Pharmaceuticals at the time the study was conducted.
Supplementary information
Supplementary Text and Figures
Supplementary Methods, Supplementary Figures 1–4, Supplementary Tables 1–3 (PDF 342 kb)
Rights and permissions
About this article
Cite this article
Plenge, R., Cotsapas, C., Davies, L. et al. Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat Genet 39, 1477–1482 (2007). https://doi.org/10.1038/ng.2007.27
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng.2007.27
This article is cited by
-
Protein citrullination and NET formation do not contribute to the pathology of A20/TNFAIP3 mutant mice
Scientific Reports (2023)
-
No association of eight TNFAIP3 single nucleotide variants to rheumatoid arthritis in Mexicans
Molecular Biology Reports (2022)
-
Transcriptome-wide association study identifies susceptibility genes for rheumatoid arthritis
Arthritis Research & Therapy (2021)
-
The haplotypes of various TNF related genes associated with scleritis in Chinese Han
Human Genomics (2020)
-
Non-catalytic ubiquitin binding by A20 prevents psoriatic arthritis–like disease and inflammation
Nature Immunology (2020)